Photo of David Welsh

David Welsh

Dr.

  • 70 Cowcaddens Road, Glasgow Caledonian University

    G4 0BA Glasgow

    United Kingdom

20072019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David Welsh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Pulmonary Hypertension Medicine & Life Sciences
fluvastatin Medicine & Life Sciences
p38 Mitogen-Activated Protein Kinases Medicine & Life Sciences
Pulmonary Artery Medicine & Life Sciences
Lung Medicine & Life Sciences
Fibroblasts Medicine & Life Sciences
Adventitia Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

Pulmonary Hypertension
Magnetic Resonance Imaging
Dilatation
Rodentia
Cardiac Catheters
6 Downloads (Pure)

Short-term hemodynamic effects of apelin in patients with pulmonary arterial hypertension

Brash, L., Peacock, A., Newby, D. & Welsh, D., Apr 2018, In : JACC: Basic to Translational Science. 28, 2, p. 176-186

Research output: Contribution to journalArticle

Open Access
File
Pulmonary Hypertension
Hemodynamics
Hypertension
Type 5 Cyclic Nucleotide Phosphodiesterases
Lung
1 Downloads (Pure)

The role of microRNA-155/LXR pathway in experimental and Idiopathic Pulmonary Fibrosis

Kurowska-Stolarska, M., Hasoo, M. K., Welsh, D. J., Stewart, L., McIntyre, D., Morton, B. E., Johnstone, S., Miller, A. M., Asquith, D. L., Millar, N. L., Millar, A. B., Feghali-Bostwick, C. A., Hirani, N., Crick, P. J., Wang, Y., Griffiths, W. J., McInnes, I. B. & McSharry, C., Jun 2017, In : Journal of Allergy and Clinical Immunology. 139, 6, p. 1946-1956 11 p.

Research output: Contribution to journalArticle

Open Access
File
Idiopathic Pulmonary Fibrosis
MicroRNAs
Lung
Fibroblasts
Macrophages

The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension

Church, A. C., Martin, D. H., Wadsworth, R., Bryson, G., Fisher, A. J., Welsh, D. J. & Peacock, A. J., 1 Aug 2015, In : American Journal of Physiology: Lung Cellular and Molecular Physiology. 309, 4, p. L333-L347

Research output: Contribution to journalArticle

p38 Mitogen-Activated Protein Kinases
Pulmonary Hypertension
Anti-Inflammatory Agents
Lung
Vascular Diseases

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension

Shao, D., Perros, F., Caramori, G., Meng, C., Dormuller, P., Chou, P-C., Church, C., Papi, A., Casolari, P., Welsh, D., Peacock, A., Humbert, M., Adcock, I. M. & Wort, S. J., 1 Aug 2014, In : Biochemical and Biophysical Research Communications. 451, 1, p. 8-14 7 p.

Research output: Contribution to journalArticle